Biosynthesis of Membrane Lipids and Steroids
Chapter 27: Biosynthesis of Membrane Lipids and Steroids
Enzymes in Lipid Biosynthesis
Enzymes involved in lipid biosynthetic pathways are significant targets for drug development due to their crucial roles in metabolism and disease.
Statins: A class of drugs that competitively inhibit HMG-CoA reductase, which is the rate-limiting and committed step in cholesterol biosynthesis. By blocking this key enzyme, statins effectively lower intracellular cholesterol levels, thereby aiding in managing hypercholesterolemia and preventing cardiovascular diseases.
Learning Goals of Chapter 27
By the end of this chapter, students should be able to:
Identify the relationship between triacylglycerol and phospholipid synthesis, recognizing phosphatidate as a common precursor.
Distinguish the first stage of cholesterol biosynthesis (mevalonate formation) and specifically identify the committed, rate-limiting step catalyzed by HMG-CoA reductase.
Identify regulatory processes that control cholesterol synthesis, including transcriptional regulation via SREBP, protein degradation of HMG-CoA reductase, and allosteric control.
Identify important molecules synthesized from cholesterol precursors and cholesterol itself, such as bile salts, steroid hormones, and Vitamin D.
Identify genetic diseases associated with defects in these processes, like Tay-Sachs disease and familial hypercholesterolemia.
Key Intermediates and Energy Source:
Phosphatidate (diacylglycerol 3-phosphate): Serves as a vital branch point, directing synthesis towards either phospholipids or triacylglycerols. It is initially formed from glycerol 3-phosphate and two fatty acyl CoAs.
HMG-CoA: A central intermediate in cholesterol and ketone body synthesis. Statins specifically target the reduction of HMG-CoA to mevalonate in cholesterol biosynthesis.
Outline of Chapter 27
27.1 Phosphatidate Is a Common Intermediate in the Synthesis of Phospholipids and Triacylglycerols, acting as a precursor for both vital lipid classes.
27.2 Cholesterol Is Synthesized from Acetyl Coenzyme A in Three Stages, detailing the transformation from a simple two-carbon unit to a complex steroid molecule.
27.3 The Regulation of Cholesterol Biosynthesis Takes Place at Several Levels, highlighting the intricate mechanisms controlling cellular cholesterol homeostasis.
27.4 Important Biochemicals Are Synthesized from Cholesterol and Isoprene, demonstrating the diverse functions of cholesterol as a precursor for other essential molecules.
27.1 Phosphatidate as a Common Intermediate
Phosphatidate (diacylglycerol 3-phosphate):
A ubiquitous and crucial common intermediate in the synthesis pathways for both phospholipids and triacylglycerols.
Synthesized primarily in the endoplasmic reticulum (ER) and, to a lesser extent, the outer mitochondrial membrane in mammalian cells. Its synthesis involves the acylation of glycerol 3-phosphate with two fatty acyl CoAs.
Triacylglycerol Synthesis
Primarily occurs in the liver, adipose tissue, and intestinal cells, where excess energy is stored as fat.
Phosphatidic acid phosphatase (Lipin): This enzyme specifically hydrolyzes the phosphate group from phosphatidate, yielding 1,2-diacylglycerol (DAG). This step commits the precursor to triacylglycerol synthesis.
Diacylglycerol acyltransferase (DGAT): This enzyme, in the final step, acetylates DAG with a third fatty acyl CoA, forming triacylglycerol.
Both enzymes, phosphatidic acid phosphatase and diglyceride acyltransferase, are integral components of the triacylglycerol synthetase complex, tightly associated with the ER membrane.
Sphingolipids from Ceramide
Sphingolipids:
A diverse class of membrane lipids characterized by a sphingosine backbone rather than a glycerol backbone. They are highly prevalent in eukaryotic cell membranes, particularly enriched in the central nervous system, where they play vital roles in cell recognition and signal transduction.
Example: In sphingomyelin, a major component of myelin sheaths, the substituent attached to the primary hydroxyl group of ceramide is phosphorylcholine (or phosphoethanolamine).
Ceramide:
The foundational lipid in sphingolipid synthesis, consisting of a fatty acid attached via an amide linkage to the amino group of a sphingosine backbone (a long-chain amino alcohol).
Its synthesis begins with the condensation of serine and palmitoyl CoA. The initial product in sphingolipid synthesis, ceramide can then be modified by the addition of various head groups.
In cerebrosides, the simplest glycosphingolipids, a single sugar residue (such as glucose or galactose) is attached to the terminal hydroxyl group of ceramide. UDP-glucose or UDP-galactose serve as the activated sugar donors for these reactions.
Gangliosides
Gangliosides:
Considered the most complex class of sphingolipids due to their elaborate oligosaccharide chains.
They feature an oligosaccharide chain, which includes at least one acidic sugar, typically sialic acid (N-acetylneuraminate or N-glycolylneuraminate), linked to the terminal hydroxyl group of ceramide.
The assembly of these complex oligosaccharide chains involves the sequential addition of sugar residues to ceramide. This process requires activated sugar donors (e.g., UDP-glucose, UDP-galactose, UDP-N-acetylgalactosamine, UDP-N-acetylglucosamine) and CMP-N-acetylneuraminate as the donor for sialic acid residues. Gangliosides are crucial for cell-cell recognition, adhesion, and signal transduction.
Tay–Sachs Disease
A severe genetic condition classified as a lysosomal storage disorder. It results from a disruption in lipid metabolism due to the inherited inability to properly degrade GM2 gangliosides.
The disease is caused by a deficiency in the lysosomal enzyme beta-hexosaminidase A (Hex A), which is essential for the hydrolysis of the terminal N-acetylgalactosamine from GM2 gangliosides, preventing its conversion to GM3.
The resultant accumulation of GM2 ganglioside within neurons leads to progressive neurodegeneration. Affected neurons become swollen and are observed to be filled with lipid-filled lysosomes.
Genetic testing, often involving enzyme assays or DNA analysis, can accurately identify carries and diagnose the condition.
Symptoms typically manifest in infancy, including progressive weakness, loss of motor skills, intellectual disability, and a characteristic "cherry-red spot" in the macula of the eye. The condition is rapidly progressive, usually leading to death before age 3.
Electron microscopy of affected neurons reveals lysosomes with concentric lamellar lipid accumulations, classically described as having an "onion-skin" or "whorled" appearance.
The Mechanism of GM2 Accumulation
The ganglioside GM2 normally undergoes sequential degradation in lysosomes. The enzyme beta-N-acetylhexosaminidase A (Hex A) is responsible for removing the terminal N-acetylgalactosamine residue from GM2, converting it to GM3.
In Tay-Sachs disease, the lack or severe deficiency of functional Hex A leads to the complete halt of GM2 degradation. Consequently, GM2 ganglioside accumulates to toxic levels within the lysosomes of neurons, impairing cellular function and leading to cell death.
The ganglioside GM1, composed of five monosaccharides linked to ceramide, is a precursor to GM2 and other gangliosides, and its degradation is handled by a different enzyme, eta-galactosidase.
27.2 Cholesterol Biosynthesis
Cholesterol:
A vital steroid molecule that modulates the fluidity and permeability of animal cell membranes. It also serves as a crucial precursor for the synthesis of all steroid hormones, bile salts, and vitamin D.
It is a complex molecule composed of 27 carbon atoms, all of which are ultimately derived from acetyl CoA through a highly regulated, three-stage synthesis process:
Stage 1: Synthesis of Mevalonate: Occurs in the cytoplasm and involves the reduction of HMG-CoA.
Stage 2: Conversion of Mevalonate to Activated Isoprenoids: Occurs in the cytoplasm, generating isopentenyl pyrophosphate.
Stage 3: Condensation of Activated Isoprenoids to Squalene and Cyclization to Cholesterol: Predominantly occurs in the endoplasmic reticulum.
Step 1 (Committed Step): HMG-CoA reductase catalyzes the irreversible reduction of 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) to mevalonate. This is the rate-limiting and primary regulatory step in cholesterol biosynthesis.
Reaction:
3-Hydroxy-3-Methylglutaryl \; CoA + 2 NADPH + 2 H^+ \rightarrow Mevalonate + 2 NADP^+ + CoA
This reaction consumes two molecules of NADPH, highlighting its energy-intensive nature.
HMG-CoA Fates
HMG-CoA is a pivotal intermediate with different metabolic fates depending on its cellular location:
In the cytoplasm, HMG-CoA is committed to cholesterol biosynthesis by being irreversibly converted to mevalonate catalyzed by HMG-CoA reductase.
In the mitochondria, HMG-CoA liaison with acetoacetyl CoA, leading to the formation of ketone bodies (acetoacetate and eta-hydroxybutyrate), which serve as alternative fuel sources during fasting or starvation. Here, HMG-CoA lyase cleaves HMG-CoA into acetyl CoA and acetoacetate.
Statins
Statins are highly effective pharmaceuticals that function as competitive inhibitors of HMG-CoA reductase. Their structural similarity to the HMG-CoA substrate allows them to bind to the active site of the enzyme, blocking its catalytic activity.
Examples include commonly prescribed drugs such as Lipitor (atorvastatin), Mevacor (lovastatin), and Crestor (rosuvastatin).
By blocking the committed and rate-limiting step in cholesterol biosynthesis, statins significantly decrease the endogenous production of cholesterol, primarily in the liver. This reduction also triggers an upregulation of LDL receptors on the surface of liver cells, leading to increased clearance of LDL cholesterol from the bloodstream.
Stage 3: Formation of Cholesterol
The final stage of cholesterol biosynthesis involves the conversion of the linear 30-carbon molecule squalene into the tetracyclic steroid structure of cholesterol.
Squalene epoxidase first adds an oxygen atom to squalene, forming squalene epoxide, which then cyclizes to form the initial steroid intermediate, lanosterol, catalyzed by oxidosqualene cyclase. This cyclization is a complex, enzyme-catalyzed reaction that forms the characteristic four-ring structure.
The conversion of lanosterol (a C30 molecule) to cholesterol (a C27 molecule) is a multi-step process involving 19 distinct enzymatic reactions. These steps include the removal of three methyl groups, reduction of a double bond, and the repositioning of another double bond, ultimately yielding cholesterol.
27.3 Regulation of Cholesterol Biosynthesis
Cholesterol can be obtained through dietary consumption or can be synthesized de novo by the body, predominantly in the liver and intestines, which are the primary sites for its biosynthesis.
The body maintains precise cholesterol homeostasis through multiple, sophisticated regulatory mechanisms acting at several levels, primarily mediated by changes in the amount and activity of HMG-CoA reductase, as well as other regulatory proteins.
Regulation can be short-term (allosteric and covalent modification of HMG-CoA reductase) or long-term (transcriptional control of HMG-CoA reductase and LDL receptor genes, and control of HMG-CoA reductase degradation).
Sterol Regulatory Element Binding Protein (SREBP)
SREBP is a family of membrane-bound transcription factors (SREBP-1 and SREBP-2) that play a central role in regulating gene expression related to lipid synthesis, including the gene for HMG-CoA reductase and the LDL receptor.
When cellular cholesterol levels are low, SREBP, which is normally complexed with SCAP (SREBP cleavage-activating protein) and anchored in the ER membrane by Insig, is released. The SCAP-SREBP complex then translocates from the ER to the Golgi complex.
In the Golgi, SREBP undergoes sequential proteolytic cleavage by site-1 and site-2 proteases, releasing its active N-terminal domain. This active domain then relocates to the nucleus, where it binds to sterol regulatory elements (SREs) in the promoter regions of target genes, activating their transcription to promote cholesterol synthesis and uptake (e.g., HMG-CoA reductase, LDL receptor).
Role of Insig
Insig proteins (Insig-1 and Insig-2) act as key cholesterol sensors.
In the presence of high cholesterol levels, cholesterol directly binds to SCAP. This binding induces a conformational change in SCAP, allowing it to interact more strongly with Insig proteins.
Insig then anchors the SCAP-SREBP complex within the ER membrane, preventing its movement to the Golgi complex. This inhibition of SREBP activation effectively shuts down the transcription of genes involved in cholesterol synthesis, preventing unnecessary de novo synthesis when cholesterol is abundant.
Degradation of HMG-CoA Reductase
The cellular levels of HMG-CoA reductase are also regulated through controlled protein degradation.
Increased cholesterol levels (specifically, oxysterols, cholesterol metabolites) result in structural changes within the membrane-spanning domain of HMG-CoA reductase. These conformational changes promote the binding of the reductase to Insig proteins.
The Insig-bound reductase then becomes a substrate for ubiquitination by an associated ligase. Ubiquitination targets the enzyme for degradation by the proteasome, an ATP-dependent proteolytic complex, thus rapidly reducing the amount of active enzyme and further decreasing cholesterol synthesis.
Transportation of Lipids in Body Fluids
Since cholesterol and triacylglycerols are highly hydrophobic, they are packaged into specialized supramolecular assemblies called lipoproteins for transport between tissues via the aqueous environment of blood and lymph.
Lipoproteins consist of a nonpolar, hydrophobic core (containing triacylglycerols and cholesteryl esters) surrounded by a polar, hydrophilic shell composed of phospholipids, free cholesterol, and specialized proteins called apolipoproteins (or apoproteins). These apolipoproteins not only enhance the solubility of lipids but also provide structural stability, act as enzyme cofactors, and serve as ligands for specific cell surface receptors.
A critical aspect of cholesterol metabolism is that mammalian cells cannot degrade the stable steroid nucleus of cholesterol. Therefore, excess cholesterol must either be utilized (e.g., for hormone synthesis) or transported to the liver for excretion (e.g., as bile acids).
Generic Lipoprotein Structure
Typical lipoprotein compositions include:
Apolipoproteins: Protein components vital for structure, enzyme activation, and receptor binding.
Polar lipids: Such as phospholipids and free cholesterol that form the outer shell.
Hydrophobic lipids: Triglycerides (up to 90% in chylomicrons) and cholesteryl esters (the esterified, more hydrophobic form of cholesterol), which reside in the core.
Free cholesterol: Situated partially in the outer shell.
Classification of Lipoprotein Particles by Density
Lipoprotein particles are classified based on their increasing density, which largely correlates with their protein-to-lipid ratio. Higher density indicates a higher protein percentage and lower lipid percentage:
Chylomicron: Density < 1.006 \; g/mL. These are the largest and least dense lipoproteins, high in triacylglycerides (~90%). They are primarily responsible for transporting dietary fats (exogenous pathway) and fat-soluble vitamins from the intestines to peripheral tissues and the liver.
Very Low-Density Lipoprotein (VLDL): Density < 1.006 \; g/mL. Synthesized in the liver, VLDLs transport endogenous fats (triacylglycerides) synthesized in the liver to peripheral tissues.
Intermediate-Density Lipoprotein (IDL): Density 1.006–1.019 \; g/mL. IDLs are metabolic intermediates formed from VLDL after the removal of a significant portion of their triacylglycerides by lipoprotein lipase. They are either taken up by the liver or further metabolized into LDL.
Low-Density Lipoprotein (LDL): Density 1.019–1.063 \; g/mL. Often referred to as "bad cholesterol," LDL is the major cholesterol carrier in the blood, delivering cholesterol to peripheral cells via the LDL receptor. High levels of LDL are associated with an increased risk of cardiovascular disease.
High-Density Lipoprotein (HDL): Density 1.063–1.21 \; g/mL. Known as "good cholesterol," HDL is synthesized in the liver and intestines. Its primary function is unique: it acts in reverse cholesterol transport, removing excess cholesterol from peripheral cells and transporting it back to the liver for excretion or recycling.
Characteristics of Plasma Lipoproteins
Chylomicrons: Have a major lipid constituent of dietary triglycerides and lesser amounts of cholesterol. Major apolipoproteins include B-48 (structural), E, A-I, A-IV, and C-family apolipoproteins (C-I, C-II, C-III) acquired in circulation, with C-II being a crucial activator of lipoprotein lipase.
VLDL and IDL: Primarily transport endogenous triglycerides and cholesterol. VLDL contains apolipoprotein B-100 (structural) and C-family proteins. As VLDL loses triglycerides and becomes IDL, it retains B-100 and typically apolipoprotein E.
LDL: Is rich in cholesteryl esters and contains a single large apolipoprotein, B-100, which is critically recognized by the LDL receptor for cellular uptake. It is derived from VLDL/IDL metabolism.
HDL: Contains phospholipids and cholesteryl esters. Its major apolipoproteins are A-I (essential for activating LCAT, lecithin-cholesterol acyltransferase, which esterifies cholesterol), A-II, E, and C-I, C-II, C-III. HDL plays a key role in removing free cholesterol from cells.
27.4 Other Important Biochemicals from Cholesterol
Bile Salts: These are the major metabolic products and the most significant pathway for cholesterol elimination from the body. Synthesized in the liver from cholesterol, they are stored in the gallbladder and released into the small intestine after fatty meal ingestion.
Bile salts function as powerful biological detergents due to their amphipathic nature (having both hydrophilic and hydrophobic regions). They effectively emulsify dietary lipids in the small intestine, increasing the effective surface area for lipase action and promoting the formation of micelles, which enhances the absorption of dietary fats and fat-soluble vitamins by intestinal cells. A significant portion of bile salts is reabsorbed in the ileum and returned to the liver via enterohepatic circulation.
Bile Salts Structure
The synthesis of bile salts from cholesterol involves several steps, including the addition of polar hydroxyl groups and the shortening of the hydrocarbon tail. These modifications render cholesterol more hydrophilic. Furthermore, bile acids are often conjugated with glycine or taurine to form bile salts (e.g., glycocholate, taurocholate), which further increases their hydrophilicity and effectiveness as detergents at intestinal pH.
Steroid Hormones Derived from Cholesterol
Cholesterol serves as the fundamental precursor to all five major classes of steroid hormones, which are lipophilic signaling molecules that regulate a wide range of physiological processes. The first committed step in all steroid hormone synthesis is the conversion of cholesterol (C27) to pregnenolone (C21) via enzymatic cleavage of its side chain.
Progesterone: A C21 steroid, primarily produced in the corpus luteum and placenta. It plays a critical role in preparing the uterine lining for ovum implantation, maintaining pregnancy by preventing premature uterine contractions, and influencing the ovarian cycle.
Glucocorticoids (e.g., cortisol): C21 steroids, synthesized in the adrenal cortex. They are essential for stress response, carbohydrate metabolism (promoting gluconeogenesis and glycogen synthesis), inhibiting inflammation, and regulating blood pressure and immune function.
Mineralocorticoids (e.g., aldosterone): C21 steroids, also produced in the adrenal cortex. Their primary function is to control sodium reabsorption and potassium excretion in the kidneys, thereby regulating electrolyte balance, blood volume, and blood pressure.
Androgens (e.g., testosterone): C19 steroids, mainly produced in the testes in males and, to a lesser extent, in the adrenal cortex and ovaries. They are responsible for the development of male primary and secondary sex characteristics, muscle mass, and libido.
Estrogens (e.g., estradiol): C18 steroids, predominantly synthesized in the ovaries, placenta, and adrenal cortex. They are crucial for the development of female secondary sex characteristics, regulating the ovarian and menstrual cycles, and maintaining bone density.
Classes of Steroid Hormones Derived from Cholesterol
The following diagram summarizes the intricate conversion pathway from common cholesterol precursor to various classes of steroid hormones, emphasizing the stepwise reduction in carbon atoms and functional group modifications:
Cholesterol (C27): The initial 27-carbon precursor.
Conversion to Pregnenolone (C21): The first committed step, involving C27 to C21 side-chain cleavage.
From Pregnenolone, further conversions lead to:
Progesterone (C21)
Glucocorticoids (e.g., Cortisol - C21)
Mineralocorticoids (e.g., Aldosterone - C21)
Androgens (e.g., Testosterone - C19): Involves the removal of two more carbons.
Estrogens (e.g., Estradiol - C18): Aromatization of androgens, resulting in one less carbon and an aromatic A-ring.